Considering the critical role of anti-apoptotic BCL-2 proteins in apoptosis resistance by cancer cells, selective drugs designed to inhibit anti-apoptotic BCL-2 proteins, termed BH3 mimetics, have been developed. The gene discussed is BCL2; the disease is cancer.